Australia 3D Imaging Market Analysis Report 2022 to 2030

Australia 3D Imaging Market Analysis

$ 3999

Australia's 3D imaging market is projected to grow from $ 0.36 Bn in 2022 to $ 1.37 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. The market will be driven by the rising chronic illness incidence and the increasing demand for less invasive treatments. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Philips Healthcare, Siemens Healthineers & Australian imaging.

ID: IN10AUDH001 CATEGORY: Digital Health GEOGRAPHY: Australia AUTHOR: Vidhi Upadhyay

Buy Now

Australia 3D Imaging Market Executive Summary

Australia's 3D imaging market is projected to grow from $ 0.36 Bn in 2022 to $ 1.37 Bn by 2030, registering a CAGR of 18% during the forecast period of 2022-30. Australia’s total health expenditures in 2022-23 are expected to be $105.8 Bn, accounting for 16.8% of total Australian government spending. Australia's healthcare system is regarded as high-quality, with well-trained medical staff and innovative medical technology available to patients. It ranks 6^th in healthcare globally with robust public as well as private health sector involvement. Cardiovascular diseases (coronary heart disease and stroke), dementia and Alzheimer's disease, lung cancer, and chronic lower respiratory disease, including COPD, are the most prevalent underlying reasons, accounting for 40% of all fatalities in Australia making it a large market space for 3D Imaging market to aid better diagnostics and treatments for patients.

In Australia, the 3D application of X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Imaging systems, and other medical imaging technologies have undoubtedly increased the ability of health professionals to detect and treat patient’s conditions. Melanoma (skin cancer) is the most common cancer in Australia, with an estimated 28,000 Australians diagnosed each year. In September 2021, Australia introduced 3D imaging for melanoma detection with the Australian Cancer Research Foundation- Australian Centre of Excellence in Melanoma Imaging and Diagnosis.

australia-3D-imaging-market-analysis

Market Dynamics

Market Growth Drivers

The 3D imaging market in Australia is being pushed by factors such as rising chronic illness incidence, a growing elderly population, technological improvements, rising demand for less invasive treatments, and government initiatives to enhance healthcare infrastructure. Furthermore, rising awareness of the benefits of early illness detection and increased expenditure in healthcare are driving the growth of the 3D imaging market in Australia.

Market Restraints

The 3D imaging industry in Australia is hampered by factors such as expensive equipment costs, a scarcity of qualified experts, poor reimbursement rates, and tight regulatory requirements. Furthermore, the lack of standardisation and compatibility across different imaging systems, as well as the restricted availability of 3D imaging in rural and distant locations, are impediments to market expansion.

Competitive Landscape

Key Players

GE Healthcare
Philips Healthcare
Siemens Healthineers
Canon Medical Systems
Toshiba Medical Systems
IMV imaging (AUS)
Australian imaging (AUS)

Notable Deals

January 2023, Canon Medical Systems Corporation announced a Partnership with ScImage, Inc., as it plans to expand in image exchange solutions and the cardiac market.
In November 2022, GE HealthCare announced partnerships with Accuray, Elekta, and RaySearch to combine GE HealthCare's imaging capabilities with precision radiation therapy to give cancer patients early diagnosis and improved treatment alternatives.

Healthcare Policies and Regulatory Landscape

In Australia, the Therapeutic Goods Administration (TGA), which is part of the Department of Health, is in charge of 3D imaging policy and regulation. The TGA is in charge of regulating medical products, including 3D imaging systems, to assure their safety, efficacy, and quality. The TGA also establishes guidelines for medical device marketing and labelling in Australia. Furthermore, the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) regulates the use of ionising radiation in medical imaging, including 3D imaging.

Reimbursement Scenario

In Australia, funding for 3D imaging is handled through Medicare, the government's major healthcare plan. The government funds the programme, which provides a variety of medical services, including diagnostic imaging. The government determines payment regulations for 3D imaging, which are subject to continuous evaluation and adjustment. Furthermore, the Australian Health Practitioner Regulation Agency (AHPRA) establishes criteria for healthcare professionals, including those who use 3D imaging and assures compliance through frequent audits and inspections.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Australia 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.